The Myriad Appeal: Federal Circuit rules that isolated DNA sequences are patent eligible subject matter under § 101 *

USA - August 9 2011
On July 29, 2011, in an opinion written by Judge Alan D. Lourie, the U.S. Court of Appeals for the Federal Circuit issued its decision in Association for Molecular Pathology, et al. v. U.S. Patent & Trademark Office, et al., --- F.3d --- (Fed. Cir. 2011), in which it held, among other things, that claims for isolated DNA sequences are patent eligible under 35 U.S.C. § 101.

Co-authors: Gwilym J. O. Attwell.